Universal Solution for Monoclonal Antibody Quantification in Biological Fluids Using Trap-Elute MicroLC-MS Method

Significance of the Topic

Quantitative analysis of monoclonal antibodies in small‐volume biological samples is critical for preclinical pharmacokinetic and pharmacodynamic studies.
Microflow liquid chromatography coupled with tandem mass spectrometry enhances detection sensitivity while immunoaffinity enrichment reduces matrix interference.

Study Objectives and Overview

This study aimed to develop a universal trap‐elute microLC‐MS/MS workflow and immunocapture approach for ultra‐sensitive quantification of a stable isotope–labeled monoclonal antibody (SILuLite) in mouse plasma.
The method was designed for easy transfer to quantitation of any human IgG–based biotherapeutic in animal matrices with minimal modification.

Methodology and Instrumentation

• Sample Preparation:
  • Streptavidin magnetic beads conjugated with biotinylated anti‐human IgG for immunocapture.
  • Mouse plasma (25 μL) spiked with SILuLite standards (2–20000 ng/mL) and internal standard (SILuMab).
  • Beads washed, eluted with 0.1% TFA, denatured, and digested with trypsin/Lys-C.
• Chromatography and MS:
  • M5 MicroLC trap‐elute system at 5 μL/min for loading and analytical separation on C18 trap and analytical columns.
  • Analysis on a QTRAP 6500+ LC‐MS/MS with OptiFlow Turbo V source and SteadySpray probe.
  • MRM transitions targeting conserved IgG peptides optimized for maximum signal-to-noise.
• Comparison Study:
  • Analytical flow LC-MS at 0.7 mL/min using Shimadzu HPLC to assess sensitivity gains.

Key Results and Discussion

The microflow immunoaffinity method achieved a lower limit of quantification of 2 ng/mL with 87–109% accuracy and CVs below 15%.
The calibration curve covered four and a half orders of magnitude (2–20000 ng/mL) with a regression coefficient of 0.996 (1/x² weighting).
Compared to analytical flow, microflow delivered over threefold increase in peak area and more than twofold improvement in signal-to-noise at low concentrations.

Benefits and Practical Applications

• High sensitivity and broad dynamic range from small‐volume samples (25 μL).
• Robust performance without extensive source optimization.
• Compatible with any IgG biotherapeutic quantitation with minimal method adaptation.
• Suitable for preclinical pharmacokinetic studies, immunogenicity assessment, and bioanalysis workflows.

Future Trends and Potential Applications

• Integration of microflow LC-MS with automated immunocapture for higher throughput.
• Expansion to other biologics such as antibody–drug conjugates and novel protein therapeutics.
• Advancements in microfluidic interfaces to further reduce sample requirements.
• Regulatory acceptance of microflow immunoaffinity LC-MS for bioanalysis in drug development.

Conclusion

The developed immunoaffinity trap-elute microLC-MS/MS workflow on the QTRAP 6500+ demonstrates universal applicability, high sensitivity, and reproducibility for monoclonal antibody quantification in small‐volume plasma samples, facilitating preclinical and translational bioanalysis.

References

1. Zhang F., Li Y., et al. Quantification of Trastuzumab in Rat Plasma using an Improved Immunoaffinity-LC-MS/MS Method. SCIEX Technical Note.